Drug recall · June 12, 2013
DOBUTamine in 5% Dextrose Injection recall
Why: Lack of Assurance of Sterility: Confirmed report of leaking in the primary container.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
DOBUTamine in 5% Dextrose Injection, USP, 250 mg Total, 1000 mcg/mL 250 mL bag, Rx only, HOPIRA, INC., LAKE FOREST, IL 60045 NDC 0409-2346-32
- Lots / codes
Lot 11-309-KL
- Quantity
- 44,748 bags
- Company
- Hospira Inc., Lake Forest, IL
- Distribution
- Nationwide and Puerto Rico
- Initiated
- April 30, 2013 · Voluntary: Firm initiated
- Classified
- June 3, 2013
- Reported
- June 12, 2013
- Ended
- October 8, 2014
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Dobutamine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.